Work

A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.9514

Authors: R. G. Maki, M. L. Hensley, J. K. Wathen, S. R. Patel, D. A. Priebat, S. Okuno, D. Reinke, P. F. Thall, R. S. Benjamin, L. H. Baker

Institutions: Mayo Clinic, Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Washington Hospital, U-M Rogel Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2282833419

Cites:

Cited by: 16

Related to: 10